Home › Trial NCT05819762
Evaluation of ClearLLab LS Screening Panel
- Trial IDNCT05819762
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorBeckman Coulter, Inc.
- Enrollment831
- Start date2023-05-25
- ConditionsHematologic Malignancy · Hematologic Neoplasms · Hematologic Diseases
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.